The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling
Open accessAbstract
BACKGROUND: The distinction between Burkitt's lymphoma and diffuse large-B-cell lymphoma is unclear. We used transcriptional and genomic profiling to define Burkitt's lymphoma more precisely and to distinguish subgroups in other types of mature aggressive B-cell lymphomas. METHODS: We performed gene-expression profiling using Affymetrix U133A GeneChips with RNA from 220 mature aggressive B-cell lymphomas, including a core group of 8 Burkitt's lymphomas that met all World Health Organization (WHO) criteria. A molecular signature for Burkitt's lymphoma was generated, and chromosomal abnormalities were detected with interphase fluorescence in situ hybridization and array-based comparative genomic hybridization. RESULTS: We used the molecular signature for Burkitt's lymphoma to identify 44 cases: 11 had the morphologic features of diffuse large-B-cell lymphomas, 4 were unclassifiable mature aggressive B-cell lymphomas, and 29 had a classic or atypical Burkitt's morphologic appearance. Also, five did not have a detectable IG-myc Burkitt's translocation, whereas the others contained an IG-myc fusion, mostly in simple karyotypes. Of the 176 lymphomas without the molecular signature for Burkitt's lymphoma, 155 were diffuse large-B-cell lymphomas. Of these 155 cases, 21 percent had a chromosomal breakpoint at the myc locus associated with complex chromosomal changes and an unfavorable clinical course. CONCLUSIONS: Our molecular definition of Burkitt's lymphoma clarifies and extends the spectrum of the WHO criteria for Burkitt's lymphoma. In mature aggressive B-cell lymphomas without a gene signature for Burkitt's lymphoma, chromosomal breakpoints at the myc locus were associated with an adverse clinical outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
Irizarry, R. A. (2003) · Biostatistics · doi:10.1093/biostatistics/4.2.249 · Cited by 10,603
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., et al. (2000) · Nature · doi:10.1038/35000501 · Cited by 9,925
Self-citationHossfeld, D. K. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf146 · Cited by 4,625
Rosenwald, A., Wright, G., Chan, W. C., Connors, J. M., Campo, E., Fisher, R. I., Gascoyne, R. D., Muller-Hermelink, H. K., Smeland, E. B., Giltnane, J. M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012914 · Cited by 3,829
Self-citationThe Non-Hodgkin's Lymphoma Classification Project (1997) · Blood · doi:10.1182/blood.v89.11.3909 · Cited by 2,461
Huber, W., von Heydebreck, A., Sültmann, H., Poustka, A., & Vingron, M. (2002) · Bioinformatics · doi:10.1093/bioinformatics/18.suppl_1.s96 · Cited by 2,440
Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues
Jaffe, E. S. (2003) · Cited by 2,141
Wright, G., Tan, B., Rosenwald, A., Hurt, E. H., Wiestner, A., & Staudt, L. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1732008100 · Cited by 1,040
Self-citationMonti, S. (2005) · Blood · doi:10.1182/blood-2004-07-2947 · Cited by 820
Clinical Relevance of BCL2, BCL6, and MYC Rearrangements in Diffuse Large B-Cell Lymphoma
Kramer, M. H. H., Hermans, J., Wijburg, E., Philippo, K., Geelen, E., van Krieken, J. H. J. M., de Jong, D., Maartense, E., Schuuring, E., & Kluin, P. M. (1998) · Blood · doi:10.1182/blood.v92.9.3152 · Cited by 499
Translocations involving c-myc and c-myc function
Boxer, L. M., & Dang, C. V. (2001) · Oncogene · doi:10.1038/sj.onc.1204595 · Cited by 479
Fiegler, H., Carr, P., Douglas, E. J., Burford, D. C., Hunt, S., Smith, J., Vetrie, D., Gorman, P., Tomlinson, I. P. M., & Carter, N. P. (2003) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.10155 · Cited by 465
Molecular Biology of Burkitt’s Lymphoma
Hecht, J. L., & Aster, J. C. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.21.3707 · Cited by 439
Ventura, R., Martín-Subero, J. I., Jones, M., McParland, J., Gesk, S., Mason, D. Y., & Siebert, R. (2006) · Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2006.050083 · Cited by 303
Self-citationPrognostic factors in aggressive non-Hodgkin's lymphoma: who has "high- risk" disease?
Shipp, M. (1994) · Blood · doi:10.1182/blood.v83.5.1165.1165 · Cited by 278
Schwaenen, C., Nessling, M., Wessendorf, S., Salvi, T., Wrobel, G., Radlwimmer, B., Kestler, H. A., Haslinger, C., Stilgenbauer, S., Döhner, H., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0304717101 · Cited by 235
Self-citationMacpherson, N., Lesack, D., Klasa, R., Horsman, D., Connors, J. M., Barnett, M., & Gascoyne, R. D. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.5.1558 · Cited by 179
State-of-the-Art Therapeutics: Diffuse Large B-Cell Lymphoma
Coiffier, B. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.015 · Cited by 178
(2016) · Elsevier eBooks · doi:10.1016/b978-0-323-39255-6.50074-0 · Cited by 134
Activation of MYC in a masked t(8;17) translocation results in an aggressive B-cell leukemia.
Gauwerky, C. E., Huebner, K., Isobe, M., Nowell, P. C., & Croce, C. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.22.8867 · Cited by 125
Martín-Subero, J. I., Harder, L., Gesk, S., Schlegelberger, B., Grote, W., Martinez-Climent, J. A., Dyer, M. J. S., Novo, F. J., Calasanz, M. J., & Siebert, R. (2002) · International Journal of Cancer · doi:10.1002/ijc.10169 · Cited by 99
Self-citation8q24 translocations in blastic transformation of mantle cell lymphoma.
Au, W. Y., Horsman, D. E., Viswanatha, D. S., Connors, J. M., Klasa, R. J., & Gascoyne, R. D. (2000) · PubMed · Cited by 42
Nacheva, E. P., Dyer, M. J. S., Fischer, P., Stranks, G., Heward, J., Marcus, R. E., Grace, C. D., & Karpas, A. (1993) · Blood · doi:10.1182/blood.v82.1.231.bloodjournal821231 · Cited by 41
Cited by
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Swerdlow, S. H., Campo, E., Pileri, S. A., Harris, N. L., Stein, H., Siebert, R., Advani, R., Ghielmini, M., Salles, G. A., Zelenetz, A. D., et al. (2016) · Blood · doi:10.1182/blood-2016-01-643569 · Cited by 7,831
Self-citationCampo, E., Swerdlow, S. H., Harris, N. L., Pileri, S., Stein, H., & Jaffe, E. S. (2011) · Blood · doi:10.1182/blood-2011-01-293050 · Cited by 2,008
Self-citationStromal Gene Signatures in Large-B-Cell Lymphomas
Lenz, G., Wright, G., Dave, S. S., Xiao, W., Powell, J., Zhao, H., Xu, W., Tan, B., Goldschmidt, N., Iqbal, J., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802885 · Cited by 1,808
Self-citationMolecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways
Lenz, G., Wright, G. W., Emre, N. C. T., Kohlhammer, H., Dave, S. S., Davis, R. E., Carty, S., Lam, L. T., Shaffer, A. L., Xiao, W., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804295105 · Cited by 995
Self-citationPrognoScan: a new database for meta-analysis of the prognostic value of genes
Mizuno, H., Kitada, K., Nakai, K., & Sarai, A. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-18 · Cited by 995
Metadata
- Authors
- Hummel, M., Bentink, S., Berger, H., Klapper, W., Wessendorf, S., Barth, T. F. E., Bernd, H.-W., Cogliatti, S. B., Dierlamm, J., Feller, A. C., Hansmann, M.-L., Haralambieva, E., Harder, L., Hasenclever, D., Kühn, M., Lenze, D., Lichter, P., Martin-Subero, J. I., Möller, P., Müller-Hermelink, H.-K., Ott, G., Parwaresch, R. M., Pott, C., Rosenwald, A., Rosolowski, M., Schwaenen, C., Stürzenhofecker, B., Szczepanowski, M., Trautmann, H., Wacker, H.-H., Spang, R., Loeffler, M., Trümper, L., Stein, H., & Siebert, R.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2006-06-08
- Volume
- 354
- Issue
- 23
- Pages
- 2419-2430
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2133131759
- Cited by
- 1,006
- References
- 25
- FWCI
- 42.49
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.